Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery

Archives of Pharmacal Research

Volumn 39, Issue 9, 2016, Pages 1181-1192

  Salatin, Sara ^a   Barar, Jaleh ^a,b   Barzegar Jalali, Mohammad ^b   Adibkia, Khosro ^b,c   Milani, Mitra Alami ^a,c   Jelvehgari, Mitra ^b,c  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brain; Hydrogel; Nanoparticles; Nasal delivery; Vaccine

Indexed keywords

ALGINIC ACID; CHITOSAN NANOPARTICLE; NANOCOMPOSITE; NANOPARTICLE; POLYMER; PULLULAN; VACCINE; HYDROGEL;

BLOOD BRAIN BARRIER; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; HUMAN; HYDROGEL; MUCOADHESION; NONHUMAN; NOSE MUCOSA; POLYMERIZATION; REVIEW; ADMINISTRATION AND DOSAGE; ANIMAL; DRUG EFFECTS; INTRANASAL DRUG ADMINISTRATION; METABOLISM; PROCEDURES;

ADMINISTRATION, INTRANASAL; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; NANOCOMPOSITES; NANOPARTICLES; NASAL MUCOSA; VACCINES;

EID: 84976347323     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-016-0782-0     Document Type: Review

References (84)

1. Adibkia K, Barzegar-Jalali M, Nokhodchi A, Siahi Shadbad M, Omidi Y, Javadzadeh Y, Mohammadi GH (2009) A review on the methods of preparation of pharmaceutical nanoparticles. Pharm Sci 15:303–314
2. Ahmed EM (2015) Hydrogel: preparation, characterization, and applications. J Adv Res 6:105–121
3. Al-Ghananeem AM, Saeed H, Florence R, Yokel RA, Malkawi AH (2010) Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses. J Drug target 18:381–388
4. Ali J, Ali M, Baboota S, Kaur Sahni J, Ramassamy C, Dao L (2010) Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Design 16:1644–1653
5. Amidi M, Mastrobattista E, Jiskoot W, Hennink WE (2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 62:59–82
6. Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W (2006) Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Rel 111:107–116
7. Anand U, Agu RU, Feridooni T (2012) Novel mucoadhesive polymers for nasal drug delivery. In: Ali DS (ed) Recent advances in novel drug carrier systems. In Tech open, Canada, pp 315–330
8. Baltzley S, Mohammad A, Malkawi AH, Al-Ghananeem AM (2014) Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles. AAPS Pharm Sci Tech 15:1598–1602
9. Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, Fu T, Tan W (2012) Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine 7:1253–1271
10. Barzegar JM, Valizadeh H, Mohammadi G, Adibkia K (2009) Analytical review of drug dissolution and release kinetic models. Pharm Sci 14:191–207
11. Birkhoff M, Leitz M, Marx D (2009) Advantages of intranasal vaccination and considerations on device selection. Ind J Pharm Sci 71:729–731
12. Boddupalli BM, Mohammed ZN, Nath RA, Banji D (2010) Mucoadhesive drug delivery system: An overview. J Adv Pharm Tech Res 1:381–387
13. Borges O, Cordeiro-da-Silva A, Tavares J, Santarém N, de Sousa A, Borchard G, Junginger HE (2008) Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles. Eur J Pharm Biopharm 69:405–416
14. Chaturvedi M, Kumar M, Pathak K (2011) A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Tech Res 2:215–222
15. Corace G (2012) Multifunctional nanocarriers encapsulating anti-Alzheimer drug for nasal delivery to central nervous system. Alma Mater D L. doi:10.6092/unibo/amsdottorato/4545
16. De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3:133–149
17. De Wolf A (2007) Search Results for: combinational. Future Directions in Human Cryopreservation Combinational Pharmacotherapy. The Institute for Evidence-Based Cryonics. http://evidencebasedcryonics.org/articles. Accessed 26 Nov 2007.
18. Debache K, Kropf C, Schütz C, Harwood L, Käuper P, Monney T, Rossi N, Laue C, McCullough KC, Hemphill A (2011) Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites. Parasite Immunol 33:81–94
19. Deepak K, Kumar MS, Mahadevan N (2012) Thiolated chitosan: modified advanced generation of mucoadhesive polymers. Int J Recent Adv Pharm Res 2:31–41
20. Djupesland PG (2013) Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review. Drug Deliv Transl Res 3:42–62
21. Donovan MD, Huang Y (1998) Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption. Adv Drug Deliv Rev 29:147–155
22. Dzung NA, Hà NTN, Van DTH, Phuong NTL, Quynh NTN, Hiep DM, Hiep LV (2011) Chitosan nanoparticle as a novel delivery system for A/H1n1 influenza vaccine: safe property and immunogenicity in mice. World Acad Sci Eng Tech 60:1839–1846
23. Elnaggar YS, Etman SM, Abdelmonsif DA, Abdallah OY (2015) Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in alzheimer’s disease: optimization, biological efficacy, and potential toxicity. J Pharm Sci 104:3544–3556
24. Fini A, Bergamante V, Ceschel GC (2011) Mucoadhesive gels designed for the controlled release of chlorhexidine in the oral cavity. Pharm 3:665–679
25. Fukuyama Y, Yuki Y, Katakai Y, Harada N, Takahashi H, Takeda S, Mejima M, Joo S, Kurokawa S, Sawada S, Shibata H, Park EJ, Fujihashi K, Briles DE, Yasutomi Y, Tsukada H, Akiyoshi K, Kiyono H (2015) Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques. Mucosal Immunol 8:1144–1153
26. Gaharwar AK, Peppas NA, Khademhosseini A (2014) Nanocomposite hydrogels for biomedical applications. Biotech Bioengin 111:441–453
27. Giese M (2013) Molecular Vaccines: From Prophylaxis to Therapy. Springer, Switzerland
28. Gonçalves C, Pereira P, Gama M (2010) Self-assembled hydrogel nanoparticles for drug delivery applications. Materials 3:1420–1460
29. Gupta P, Vermani K, Garg S (2002) Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today 7:569–579
30. Hamidi M, Azadi A, Rafiei P (2008) Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 60:1638–1649
31. Haque S, Md S, Sahni JK, Ali J, Baboota S (2014) Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression. J Psychiatr Res 48:1–12
32. Ikuta Y, Katayama N, Wang L, Okugawa T, Takahashi Y, Schmitt M, Gu X, Watanabe M, Akiyoshi K, Nakamura H, Kuribayashi K, Sunamoto J, Shiku H (2002) Presentation of a major histocompatibility complex class 1–binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide–truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy. Blood 99:3717–3724
33. Illum L (2007) Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? J Pharm Sci 96:473–483
34. Jagtap P, Jadhav K, Dand N (2015) Formulation and ex vivo Evaluation of Solid Lipid Nanoparticles (SLNS) Based Hydrogel for Intranasal Drug Delivery. Int J Med Health Biomed Bioeng Pharm Eng 9:43–53
35. Kabanov AV, Vinogradov SV (2009) Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed 48:5418–5429
36. Khairnar G, Sayyad F (2010) Development of buccal drug delivery system based on mucoadhesive polymers. Int J Pharm Tech Res 2:719–735
37. Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP (2008) Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int J Pharm 354:235–241
38. Khom TC, Yadav HK, Raizaday A, Manne N, Kumar HS, Kumar SN (2014) Development of Mucoadhesive Nanoparticulate System of Ebastine for Nasal Drug Delivery. Trop J Pharm Res 13:1013–1019
39. Kobiyama K, Aoshi T, Narita H, Kuroda E, Hayashi M, Tetsutani K, Koyama S, Mochizuki S, Sakurai K, Katakai Y, Yasutomi Y, Saijo S, Iwakura Y, Akira S, Coban C, Ishii KJ (2014) Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist. Proc Natl Acad Sci U S A 111:3086–3091
40. Kong IG, Sato A, Yuki Y, Nochi T, Takahashi H, Sawada S, Mejima M, Kurokawa S, Okada K, Sato S, Briles DE, Kunisawa J, Inoue Y, Yamamoto M, Akiyoshi K, Kiyono H (2013) Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae. Infect Immun 81:1625–1634
41. Kumar A, Pandey AN, Jain SK (2014) Nasal-nanotechnology: revolution for efficient therapeutics delivery. Drug Deliv 23:681–693
42. Lee H, Ruane D, Law K, Ho Y, Garg A, Rahman A, Esterházy D, Cheong C, Goljo E, Sikora AG, Mucida D, Chen BK, Govindraj S, Breton G, Mehandru S (2015) Phenotype and function of nasal dendritic cells. Mucosal Immunol 8:1083–1098
43. Liu H, Ni Z, Chen Y, Wang D, Qi Y, Zhang Q, Wang S (2012) Olfactory route for cerebrospinal fluid drainage into the cervical lymphatic system in a rabbit experimental model. Neural Regen Res 7:766–771
44. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60:1650–1662
45. Malhotra M, Tomaro-Duchesneau C, Saha S, Prakash S (2013) Intranasal, siRNA delivery to the brain by TAT/MGF tagged PEGylated chitosan nanoparticles. J Pharm 2013:1–10
46. Mainardes RM, Urban MC, Cinto PO, Chaud MV, Evangelista RC, Gremião MP (2006) Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr Drug Deliv 3:275–285
47. Meenach SA, Anderson KW, Hilt JZ (2009) Hydrogel nanocomposites: biomedical applications, biocompatibility, and toxicity analysis. In: Thomas JW (ed) In Safety of nanoparticles, 1st edn. Springer, New York, pp 131–157
48. Mistry A, Stolnik S, Illum L (2009) Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 379:146–157
49. Mudshinge SR, Deore AB, Patil S, Bhalgat CM (2011) Nanoparticles: emerging carriers for drug delivery. Saudi Pharm J 19:129–141
50. Nagamoto T, Hattori Y, Takayama K, Maitani Y (2004) Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res 21:671–674
51. Nagatomo D, Taniai M, Ariyasu H, Taniguchi M, Aga M, Ariyasu T, Ohta T, Fukuda S (2015) Cholesteryl pullulan encapsulated TNF-α nanoparticles are an effective mucosal vaccine adjuvant against influenza virus. BioMed Res Int 2015:1–15
52. Nep EI, Conway BR (2011) Grewia gum 2: mucoadhesive properties of compacts and gels. Trop J Pharm Res 10:393–401
53. Nochi T, Yuki Y, Takahashi H, S-i Sawada, Mejima M, Kohda T, Harada N, Kong IG, Sato A, Kataoka N, Tokuhara D, Kurokawa S, Takahashi Y, Tsukada H, Kozaki S, Akiyoshi K, Kiyono H (2010) Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 9:572–578
54. Nochi T, Yuki Y, Akiyoshi K, Kiyono H (2014) Self-Assembled Polysaccharide Nanogels for Nasal Delivery of Biopharmaceuticals. In: Jose DN, Bruno S (eds) Mucosal delivery of biopharmaceuticals. Springer, US, pp 325–332
55. Ozsoy Y, Gungor S, Cevher E (2009) Nasal delivery of high molecular weight drugs. Molecules 14:3754–3779
56. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329–347
57. Pardeshi CV, Belgamwar VS (2013) Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv 10:957–972
58. Peek LJ, Middaugh CR, Berkland C (2008) Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 60:915–928
59. Pires A, Fortuna A, Alves G, Falcão A (2009) Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci 12:288–311
60. Rigogliuso S, Sabatino MA, Adamo G, Grimaldi N, Dispenza C, Ghersi G (2012) Polymeric nanogels: Nanocarriers for drug delivery application. Chem Eng 27:247–252
61. Ruby JJ, Pandey V (2014) Chitosan nanoparticles as a nasal drug delivery for memantine hydrochloride. Int J Pharm Pharm Sci 7:34–37
62. Sajeesh S, Sharma CP (2006) Cyclodextrin–insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm 325:147–154
63. Salamat-Miller N, Chittchang M, Johnston TP (2005) The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Delivery Rev 57:1666–1691
64. Salatin S, Jelvehgari M, Maleki-Dizaj S, Adibkia KH (2015a) A sight on protein-based nanoparticles as drug/gene delivery systems. Ther Deliv 6:1017–1029
65. Salatin S, Maleki Dizaj S, Yari Khosroushahi A (2015b) Effect of the surface modification, size, and shape on cellular uptake of nanoparticles. Cell Biol Int 39:881–890
66. Sangeetha S, Deepika K, Thrishala B, Chaitanya C, Harish G, Damodharan N (2010) Formulation and in vitro evaluation of sodium alginate nanospheres containing ofloxacin. Int J Appl Pharm 2:1–3
67. Sarei F, Dounighi NM, Zolfagharian H, Khaki P, Bidhendi SM (2013) Alginate nanoparticles as a promising adjuvant and vaccine delivery system. Ind J Pharm Sci 75:442–449
68. Shahnaz G, Vetter A, Barthelmes J, Rahmat D, Laffleur F, Iqbal J, Perera G, Schlocker W, Dünnhaput S, Augustijns P, Bernkop-Schnürch A (2012) Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Int J Pharm 428:164–170
69. Sharma V, Ali M, Baboota S, Ali J (2007) Preparation and characterization of chitosan nanoparticles for nose to brain delivery of a cholinesterase inhibitor. Ind J Pharm Sci 69:712–713
70. Shimizu T, Kishida T, Hasegawa U, Ueda Y, Imanishi J, Yamagishi H, Akiyoshi K, Otsuji E, Mazda O (2008) Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy. Biochem Biophys Res Commun 367:330–335
71. Singh D, Rashid M, Hallan SS, Mehra NK, Prakash A, Mishra N (2015) Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression. Artif Cells Nanomed Biotechnol 44:865–867
72. Sun J, Tan H (2013) Alginate-based biomaterials for regenerative medicine applications. Materials 6:1285–1309
73. Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y (2014) Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed 53:12320–12364
74. Talegaonkar S, Mishra P (2004) Intranasal delivery: An approach to bypass the blood brain barrier. Ind J Pharmacol 36:140–147
75. Teijeiro-Osorio D, Remuñán-López C, Alonso MJ (2008) New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. Biomacromolecules 10:243–249
76. Thoniyot P, Tan MJ, Karim AA, Young DJ, Loh XJ (2015) Nanoparticle-Hydrogel Composites: Concept, Design, and Applications of These Promising, Multi-Functional Materials. Adv Sci 2:1–13
77. Türker S, Onur E, Ózer Y (2004) Nasal route and drug delivery systems. Pharm World Sci 26:137–142
78. Vashist A, Ahmad S (2013) Hydrogels: smart materials for drug delivery. Orient J Chem 29:861–870
79. Vila A, Sánchez A, Janes K, Behrens I, Kissel T, Vila Jato JL, Alonso MJ (2004) Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 57:123–131
80. Vinogradov SV (2010) Nanogels in the race for drug delivery. Nanomedicine 5:165–168
81. Wen MM (2011) Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain—current development. Discov Med 11:497–503
82. Wong YC, Zuo Z (2010) Intranasal delivery—modification of drug metabolism and brain disposition. Pharm Res 27:1208–1223
83. Yao W, Peng Y, Du M, Luo J, Lb Zong (2013) Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity. Mol Pharm 10:2904–2914
84. Zhang H, Oh M, Allen C, Kumacheva E (2004) Monodisperse chitosan nanoparticles for mucosal drug delivery. Biomacromolecules 5:2461–2468